Advertisement

Prognostic Impact of Extracapsular Lymph Node Invasion on Survival in Non-small-Cell Lung Cancer: A Systematic Review and Meta-analysis

  • Seyed Vahid Tabatabaei
  • Christoph Nitche
  • Maximilian Michel
  • Kurt Rasche
  • Khosro Hekmat
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1116)

Abstract

The extracapsular tumor extension (ECE) of nodal metastasis is an important prognostic factor in different types of malignancies. However, there is a lack of recent data in patients with non-small-cell lung cancer (NSCLC). In addition, the TNM staging system does not include ECE status as a prognostic factor. This systematic review and meta-analysis has been conducted to summarize and pool existing data to determine the prognostic role of ECE in patients with lymph node-positive NSCLC. Two authors performed an independent search in PubMed using a predefined keyword list, without language restrictions with publication date since 1990. Prospective or retrospective studies reporting data on prognostic parameters in subjects with NSCLC with positive ECE or with only intracapsular lymph node metastasis were retrieved. Data were summarized using risk ratios (RR) for the survival with 95% confidence intervals (CI). The data was analyzed using Mix 2 (ref: Bax L: MIX 2.0 – Professional software for meta-analysis in Excel. Version 2.015. BiostatXL, 2016. https://www.meta-analysis-made-easy.com). There 2,105 studies were reviewed. Five studies covering a total of 828 subjects met the inclusion criteria and were included in the meta-analysis. Two hundred and ninety-eight (35.9%) patients were categorized as ECE+, of whom 54 (18.1%) survived at the end of follow-up. In the ECE-negative group, 257 patients (48.4%) survived by the end of follow-up. Thus, ECE status is associated with a significantly decreased survival rate: pooled RR 0.45 (95% CI 0.35–0.59), Q(4) = 4.06, Pvalue = 0.39, and I2 = 68.00% (95 CI 0.00–79.55%). In conclusion, ECE has a significant impact on survival in NSCLC patients and should be considered in diagnostic and therapeutic decisions in addition to the current TNM staging. Postoperative radiotherapy may be an option in ECE-positive pN1 NSCLC patients.

Keywords

Extracapsular lymph node invasion Meta-analysis Metastases Non-small-cell lung cancer Prognostic factor Survival rate 

Notes

Conflicts of Interests

The authors declare no conflicts of interest in relation to this article.

References

  1. Al Sahaf O, Myers E, Jawad M, Browne TJ, Winter DC, Redmond HP (2011) The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer. Dis Colon Rectum 54(8):982–988CrossRefGoogle Scholar
  2. Alakus H, Hölscher AH, Grass G, Hartmann E, Schulte C, Drebber U, Baldus SE, Bollschweiler E, Metzger R, Mönig SP (2010) Extracapsular lymph node spread: a new prognostic factor in gastric cancer. Cancer 116(2):309–315CrossRefGoogle Scholar
  3. Al-Alao BS, Gately K, Nicholson S, McGovern E, Young VK, O’Byrne KJ (2014) Prognostic impact of vascular and lymphovascular invasion in early lung cancer. Asian Cardiovasc Thorac Ann 22(1):55–64CrossRefGoogle Scholar
  4. Aragona AM, Cuneo NA, Soderini AH, Alcoba EB (2014) An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? Gynecol Oncol 132(3):643–648CrossRefGoogle Scholar
  5. Baiocchi G, Silva Cestari FM, Rocha RM, Lavorato-Rocha A, Maia BM, Cestari LA, Kumagai LY, Faloppa CC, Fukazawa EM, Badiglian-Filho L, Sant’ana Rodrigues I, Soares FA (2013) Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system. Eur J Surg Oncol 39(7):780–785CrossRefGoogle Scholar
  6. Belkacemi Y, Kaidar-Person O, Poortmans P, Ozsahin M, Valli MC, Russell N, Kunkler I, Hermans J, Kuten A, van Tienhoven G, Westenberg H, Breast Working Party of the EORTC Radiation Oncology Group (ROG) (2015) Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal radiotherapy (NORA) survey. Ann Oncol 26(3):529–535CrossRefGoogle Scholar
  7. Bollen EC, Theunissen PH, van Duin CJ, Drenth BM, van Noord JA, Blijham GH (1994) Clinical significance of intranodal and extranodal growth in lymph node metastases of non-small cell lung cancer. Scand J Thorac Cardiovasc Surg 28(3–4):97–102CrossRefGoogle Scholar
  8. Borghetti P, Barbera F, Bonù ML, Trevisan F, Ciccarelli S, Vitali P, Maddalo M, Triggiani L, Pasinetti N, Pedretti S, Bonetti B, Pariscenti G, Tironi A, Caprioli A, Buglione M, Magrini SM (2016) Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy. Radiol Med 121(9):696–703CrossRefGoogle Scholar
  9. Brabender J, Bollschweiler E, Hölscher AH, Strobel K, Gutschow C, Prenzel K, Grimminger P, Drebber U, Schröder W, Metzger R, Vallböhmer D (2012) The prognostic impact of extracapsular lymph node involvement in rectal cancer patients: implications for staging and adjuvant treatment strategies. Oncol Lett 3(4):825–830PubMedPubMedCentralGoogle Scholar
  10. Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Groupet RTO (2005) Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the radiation therapy oncology group--RTOG 9705. J Clin Oncol 23(15):3480–3487CrossRefGoogle Scholar
  11. Chen WC, Lai CH, Fang CC, Yang YH, Chen PC, Lee CP, Chen MF (2016) Identification of high–risk subgroups of patients with oral cavity cancer in need of postoperative adjuvant radiotherapy or chemo–radiotherapy. Medicine (Baltimore) 95(22):e3770CrossRefGoogle Scholar
  12. Dai C, Ren Y, Xie D, Zheng H, She Y, Fei K, Jiang G, Chen C (2016) Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease? J Thorac Oncol 11(10):1745–1754CrossRefGoogle Scholar
  13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefGoogle Scholar
  14. Di Giorgio A, Botti C, Sammartino P, Mingazzini P, Flammia M, Stipa V (1991) Extracapsular lymph node metastases in the staging and prognosis of gastric cancer. Int Surg 76(4):218–221PubMedGoogle Scholar
  15. Duran-Cantolla J, González Macías JJ, Agüero Balbín R, Carbajo Carbajo M, Ortega Morales FJ, Hernández Alonso M, Ondiviela Gracia R (1994) The prognosis of mediastinal lymph node infiltration (N2) in patients with non–small–cell lung carcinoma (NSCLC) who have undergone curative treatment. Arch Bronconeumol 30(4):196–201 (Article in Spanish)Google Scholar
  16. Eckel SP, Cockburn M, Shu YH, Deng H, Lurmann FW, Liu L, Gilliland FD (2016) Air pollution affects lung cancer survival. Thorax 71(10):891–898CrossRefGoogle Scholar
  17. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Dilling TJ, Govindan R, Grannis FW Jr, Horn L, Jahan TM, Komaki R, Kris MG, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild S, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M (2014) Non-small cell lung cancer, version 1.2015. J Natl Compr Cancer Netw 12(12):1738–1761CrossRefGoogle Scholar
  18. Fons G, Hyde SE, Buist MR, Schilthuis MS, Grant P, Burger MP, van der Velden J (2009) Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 19(7):1276–1280CrossRefGoogle Scholar
  19. Fujii T, Yajima R, Tatsuki H, Kuwano H (2016) Prediction of extracapsular invasion at metastatic sentinel nodes and non-sentinel lymph nodal metastases by FDG-PET in cases with breast cancer. Anticancer Res 36(4):1785–1789PubMedGoogle Scholar
  20. Gatzinsky P, Berglin E, Dernevik L, Larsson I, William-Olsson G (1985) Resectional operations and long–term results in carcinoma of the esophagus. J Thorac Cardiovasc Surg 89(1):71–76PubMedGoogle Scholar
  21. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L, International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2(8):706–714CrossRefGoogle Scholar
  22. Gomez DR, Komaki R (2012) Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies. Cancers (Basel) 4(1):307–322CrossRefGoogle Scholar
  23. Gu Y, Shi H, Su C, Chen X, Zhang S, Li W, Wu F, Gao G, Wang H, Chu H, Zhou C, Zhou F, Ren S (2017) The role of endobronchial ultrasound elastography in the diagnosis of mediastinal and hilar lymph nodes. Oncotarget 8(51):89194–89202CrossRefGoogle Scholar
  24. Higgins, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefGoogle Scholar
  25. Hui Z, Dai H, Liang J, Lv J, Zhou Z, Feng Q, Xiao Z, Chen D, Zhang H, Yin W, Wang L (2015) Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy. Thorac Cancer 6(3):346–353CrossRefGoogle Scholar
  26. Igai H, Matsuura N, Tarumi S, Chang SS, Misaki N, Go T, Ishikawa S, Yokomise H (2011) Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors. Eur J Cardiothorac Surg 39(6):963–967CrossRefGoogle Scholar
  27. Jing X et al (2016) Delineation of clinical target volume for postoperative radiotherapy in stage IIIA–pN2 non–small–cell lung cancer. Onco Targets Ther 9:823–831PubMedPubMedCentralGoogle Scholar
  28. Jonnalagadda S, Smith C, Mhango G, Wisnivesky JP (2011) The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer. Chest 140(2):433–440CrossRefGoogle Scholar
  29. Kelder W, Ebrahimi A, Forest VI, Gao K, Murali R, Clark JR (2012) Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread. Ann Surg Oncol 19(1):274–279CrossRefGoogle Scholar
  30. Kerr KM, Nicolson MC (2013) Prognostic factors in resected lung carcinomas. EJC Suppl 11(2):137–149CrossRefGoogle Scholar
  31. Khosrotehrani K, van der Ploeg AP, Siskind V, Hughes MC, Wright A, Thomas J, Barbour A, Allan C, Bayley G, Eggermont A, Verhoef C, Smithers BM, Green AC (2014) Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy. Eur J Cancer 50(7):1301–1309CrossRefGoogle Scholar
  32. Komori K, Kanemitsu Y, Kimura K, Sano T, Ito S, Abe T, Senda Y, Shimizu Y (2013) Detailed stratification of TNM stage III rectal cancer based on the presence/absence of extracapsular invasion of the metastatic lymph nodes. Dis Colon Rectum 56(6):726–732CrossRefGoogle Scholar
  33. Komuta K, Okudaira S, Haraguchi M, Furui J, Kanematsu T (2001) Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis Colon Rectum 44(12):1838–1844CrossRefGoogle Scholar
  34. Kuo SW, Chen JS, Huang PM, Hsu HH, Lai HS, Lee JM (2014) Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 148(4):1200–1207.e3CrossRefGoogle Scholar
  35. Lagarde SM, ten Kate FJ, de Boer DJ, Busch OR, Obertop H, van Lanschot JJ (2006) Extracapsular lymph node involvement in node–positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol 30(2):171–176CrossRefGoogle Scholar
  36. Le Péchoux C (2011) Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist 16(5):672–681CrossRefGoogle Scholar
  37. Lee YC, Wu CT, Kuo SW, Tseng YT, Chang YL (2007) Significance of extranodal extension of regional lymph nodes in surgically resected non–small cell lung cancer. Chest 131(4):993–999CrossRefGoogle Scholar
  38. Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, Fieuws S, Moons J, Nafteux P, Van Raemdonck D, Leuven Collaborative Workgroup for Esophageal Carcinoma (2003) Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 126(4):1121–1128CrossRefGoogle Scholar
  39. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefGoogle Scholar
  40. Liu W, Shao Y, Guan B, Hao J, Cheng X, Ji K, Wang K (2015) Extracapsular extension is a powerful prognostic factor in stage IIA–IIIA non–small cell lung cancer patients with completely resection. Int J Clin Exp Pathol 8(9):11268–11277PubMedPubMedCentralGoogle Scholar
  41. Luchini C, Nottegar A, Solmi M, Sergi G, Manzato E, Capelli P, Scarpa A, Veronese N (2016) Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: a systematic review and meta-analysis. Surg Oncol 25(1):60–65CrossRefGoogle Scholar
  42. Lupattelli M, Maranzano E, Bellavita R, Tarducci R, Latini R, Castagnoli P, Bufalari A, Corgna E, Pinaglia D, Rossetti R, Ribacchi R, Latini P (2001) Adjuvant radiochemotherapy in high–risk rectal cancer results of a prospective non–randomized study. Tumori 87(4):239–247CrossRefGoogle Scholar
  43. Lynch J, Lal P, Schick U, Nutting CM, Newbold K, Harrington K, Bhide S (2014) Multiple cervical lymph node involvement and extra–capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral Oncol 50(9):901–906CrossRefGoogle Scholar
  44. Maurizi G, D’Andrilli A, Venuta F, Rendina EA (2016) Reconstruction of the bronchus and pulmonary artery. J Thorac Dis 8(Suppl 2):S168–S180PubMedPubMedCentralGoogle Scholar
  45. Metindir J, Bilir Dilek G (2008) Evaluation of prognostic significance in extracapsular spread of pelvic lymph node metastasis in patients with cervical cancer. Eur J Gynaecol Oncol 29(5):476–478PubMedGoogle Scholar
  46. Metzger R, Drebber U, Baldus SE, Mönig SP, Hölscher AH, Bollschweiler E (2009) Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus. Ann Surg Oncol 16(2):447–453CrossRefGoogle Scholar
  47. Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A (2008) The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg 86(5):1626–1630CrossRefGoogle Scholar
  48. Moretti L, Yu DS, Chen H, Carbone DP, Johnson DH, Keedy VL, Putnam JB Jr, Sandler AB, Shyr Y, Lu B (2009) Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy. Oncologist 14(11):1106–1115CrossRefGoogle Scholar
  49. Naito Y, Goto K, Nagai K, Ishii G, Nishimura M, Yoshida J, Hishida T, Nishiwaki Y (2010) Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer. Chest 138(6):1411–1417CrossRefGoogle Scholar
  50. Nakamura K, Ozaki N, Yamada T, Hata T, Sugimoto S, Hikino H, Kanazawa A, Tokuka A, Nagaoka S (2005) Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Surgery 137(5):511–517CrossRefGoogle Scholar
  51. Nakano S, Baba M, Shimada M, Shirao K, Noguchi Y, Kusano C, Natsugoe S, Yoshinaka H, Fukumoto T, Aikou T (1999) How the lymph node metastases toward cervico–upper mediastinal region affect the outcome of patients with carcinoma of the thoracic esophagus. Jpn J Clin Oncol 29(5):248–251CrossRefGoogle Scholar
  52. Paraf F, Fléjou JF, Pignon JP, Fékété F, Potet F (1995) Surgical pathology of adenocarcinoma arising in Barrett’s esophagus. Analysis of 67 cases. Am J Surg Pathol 19(2):183–191CrossRefGoogle Scholar
  53. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour–enhanced meta–analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10):991–996CrossRefGoogle Scholar
  54. Pinto AP, Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL (2004) Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol 92(3):856–865CrossRefGoogle Scholar
  55. Puppa G, Maisonneuve P, Sonzogni A, Masullo M, Capelli P, Chilosi M, Menestrina F, Viale G, Pelosi G (2007) Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol 20(8):843–855CrossRefGoogle Scholar
  56. Riquet M (1996) Capsular rupture of N2 resected lymph nodes and surgery of bronchial cancer. Rev Mal Respir 13(6):535–537. (Article in French)Google Scholar
  57. Riquet M, Manac’h D, Saab M, Le Pimpec-Barthes F, Dujon A, Debesse B (1995) Factors determining survival in resected N2 lung cancer. Eur J Cardiothorac Surg 9(6):300–304CrossRefGoogle Scholar
  58. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefGoogle Scholar
  59. Suzuki H, Fujii T, Asao T, Tsutsumi S, Wada S, Araki K, Kubo N, Watanabe A, Tsukagoshi M, Kuwano H (2014) Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases. World J Surg 38(8):2079–2088CrossRefGoogle Scholar
  60. Tachikawa D, Inada S, Kotoh T, Futami K, Arima S, Iwashita A (1999) An evaluation of malignancy and prognostic factors based on mode of lymph node metastasis in esophageal carcinoma. Surg Today 29(11):1131–1135CrossRefGoogle Scholar
  61. Taghavi N, Yazdi I (2015) Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med 18(5):314–319PubMedGoogle Scholar
  62. Torre LA, Siegel RL, Jemal A (2016) Lung cancer statistics. Adv Exp Med Biol 893:1–19CrossRefGoogle Scholar
  63. Ueno H, Mochizuki H, Tamakuma S (1998) Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 41(1):55–61CrossRefGoogle Scholar
  64. van der Steen S, de Nieuwenhof HP, Massuger L, Bulten J, de Hullu JA (2010) New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecol Oncol 119(3):520–525CrossRefGoogle Scholar
  65. Van Schil PE, Balduyck B, De Waele M, Hendriks JM, Hertoghs M, Lauwers P (2013) Surgical treatment of early-stage non-small-cell lung cancer. EJC Suppl 11(2):110–122CrossRefGoogle Scholar
  66. Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, Demedts MG (1997) Survival and prognostic factors in resected N2 non–small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group Ann Thorac Surg 63(5):1441–1450CrossRefGoogle Scholar
  67. Veronese N, Nottegar A, Pea A, Solmi M, Stubbs B, Capelli P, Sergi G, Manzato E, Fassan M, Wood LD, Scarpa A, Luchini C (2016) Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis. Ann Oncol 27(1):42–48CrossRefGoogle Scholar
  68. Wang S, Wu Y, Ou W (2001) Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 23(3):259–261PubMedGoogle Scholar
  69. Wind J, Lagarde SM, Ten Kate FJ, Ubbink DT, Bemelman WA, van Lanschot JJ (2007) A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies. Eur J Surg Oncol 33(4):401–408CrossRefGoogle Scholar
  70. Wisnivesky JP, Arciniega J, Mhango G, Mandeli J, Halm EA (2011) Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax 66(4):287–293CrossRefGoogle Scholar
  71. Zacho A, Fischermann K, Soresen BL (1963) Prognostic role of breach of lymph node capsule in nodal metastates from gastric carcinoma. Acta Chir Scand 125:365–369PubMedGoogle Scholar
  72. Zaric B, Stojsic V, Tepavac A, Sarcev T, Zarogoulidis P, Darwiche K, Tsakiridis K, Karapantzos I, Kesisis G, Kougioumtzi I, Katsikogiannis N, Machairiotis N, Stylianaki A, Foroulis CN, Zarogoulidis K, Perin B (2013) Adjuvant chemotherapy and radiotherapy in the treatment of non–small cell lung cancer (NSCLC). J Thorac Dis 5(Suppl 4):S371–S377PubMedPubMedCentralGoogle Scholar
  73. Zhang B, Zhao L, Yuan Z, Pang Q, Wang P (2016) The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients. Onco Targets Ther 9:6161–6169CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Seyed Vahid Tabatabaei
    • 1
  • Christoph Nitche
    • 2
  • Maximilian Michel
    • 3
  • Kurt Rasche
    • 1
  • Khosro Hekmat
    • 4
  1. 1.Department of Internal Medicine, Division of Pulmonary, Allergy, and Sleep Medicine, HELIOS Clinic WuppertalWitten/Herdecke UniversityWuppertalGermany
  2. 2.Department of Internal MedicineMarien Hospital Euskirchen, Teaching Hospital of Uniklinik BonnEuskirchenGermany
  3. 3.Institute of Zoology, University of CologneCologneGermany
  4. 4.Department of Cardiothoracic SurgeryUniversity Clinic of CologneCologneGermany

Personalised recommendations